Last 301.20
Change Today +2.40 / 0.80%
Volume 4.8K
BIOV On Other Exchanges
Tel Aviv
As of 10:24 AM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

bio view ltd (BIOV) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/14/14 - $388.00
52 Week Low
12/26/13 - $254.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO VIEW LTD (BIOV)

Related News

No related news articles were found.

bio view ltd (BIOV) Related Businessweek News

No Related Businessweek News Found

bio view ltd (BIOV) Details

BioView Ltd. develops, manufactures, assembles, markets, and services automated cell diagnostic systems for use in cytology, cytogenetics, hematology, and pathology laboratories. It offers imaging and offline analysis workstations, and biological preparation kits to medical institutions, and commercial laboratories and universities. The company’s products comprise DUET-3 and ALLEGRO PLUS scanning stations for scanning and sorting hematopoietic cells, amniocytes, cells from voided urine samples, sperm cells, metaphases, and tissues; ACCORD scanning station for analyzing breast and other tissues samples, hematopoietic cells, amniocytes, and voided urine samples; and LEGATO imaging and analysis system, a microscope expansion kit for the analysis of cell suspension and tissue based samples hybridized with fluorescent probe sets. It also provides Solo offline analysis workstation for offline analysis of cases; SoloWeb, a Web based review, analysis, and reporting software for tissue and cell suspension samples laboratory reporting; and ThermoBrite Elite, an automated laboratory assistant for sample preparation, as well as BioView reagent kits for the preparation of peripheral blood, bone marrow, and uncultured amniocytes samples for scanning. It has operations primarily in Israel and North America. The company was founded in 2000 and is headquartered in Nes Ziona, Israel.

Founded in 2000

bio view ltd (BIOV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bio view ltd (BIOV) Key Developments

Bio View Ltd., Special/Extraordinary Shareholders Meeting, Aug 25, 2013

Bio View Ltd., Special/Extraordinary Shareholders Meeting, Aug 25, 2013., at 11:00 Israel Standard Time.

Bio View Ltd. and Kindstar Global Co.,Ltd to Launch Pilot Study of the BioView Lung Cancer Detection Kit in China

Bio View Ltd. and Kindstar Global Co.,Ltd have agreed to launch a pilot study of the BioView lung cancer detection kit in China. As part of the agreement, following the Pilot Study, Kindstar will have an option to negotiate a license agreement with BioView to market the lung cancer test in China. The terms of the agreement grant Kindstar 12 months to inform BioView if they wish to exercise the option.

Bio View Ltd., Special/Extraordinary Shareholders Meeting, May 19, 2013

Bio View Ltd., Special/Extraordinary Shareholders Meeting, May 19, 2013., at 11:00 Israel Standard Time.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOV:IT 301.20 +2.40

BIOV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOV.
View Industry Companies

Industry Analysis


Industry Average

Valuation BIOV Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO VIEW LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at